Janney Montgomery Scott
IONS icon

Janney Montgomery Scott’s Ionis Pharmaceuticals IONS Stock Holding History

Janney Montgomery Scott’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,177
Closed -$330K – 2907
2025
Q4 		$330K Buy
+4,177
New +$315K ﹤0.01% 2490
2025
Q1 		– Sell
-9,840
Closed -$344K – 2763
2024
Q4 		$344K Sell
9,840
-1,454
-13% -$54.3K ﹤0.01% 2224
2024
Q3 		$452K Sell
11,294
-6,240
-36% -$290K ﹤0.01% 2038
2024
Q2 		$836K Sell
17,534
-9,359
-35% -$384K ﹤0.01% 1545
2024
Q1 		$1.17M Sell
26,893
-1,486
-5% -$70.8K ﹤0.01% 1436
2023
Q4 		$1.44M Sell
28,379
-1,239
-4% -$59.3K ﹤0.01% 1258
2023
Q3 		$1.34M Sell
29,618
-1,485
-5% -$61.3K 0.01% 1182
2023
Q2 		$1.28M Sell
31,103
-1,505
-5% -$57.8K ﹤0.01% 1279
2023
Q1 		$1.17M Sell
32,608
-450
-1% -$16.9K ﹤0.01% 1239
2022
Q4 		$1.25M Buy
33,058
+643
+2% +$27K ﹤0.01% 1251
2022
Q3 		$1.43M Buy
32,415
+1,757
+6% +$74K 0.01% 1136
2022
Q2 		$1.14M Sell
30,658
-7,956
-21% -$300K 0.01% 1178
2022
Q1 		$1.43M Buy
38,614
+2,190
+6% +$71.7K 0.01% 1074
2021
Q4 		$1.11M Buy
36,424
+2,271
+7% +$71.5K ﹤0.01% 1268
2021
Q3 		$1.15M Sell
34,153
-4,493
-12% -$169K ﹤0.01% 1219
2021
Q2 		$1.54M Buy
38,646
+1,834
+5% +$71.8K 0.01% 1063
2021
Q1 		$1.66M Buy
36,812
+839
+2% +$46.8K 0.01% 972
2020
Q4 		$2.03M Sell
35,973
-1,402
-4% -$69.9K 0.01% 865
2020
Q3 		$1.77M Sell
37,375
-1,059
-3% -$58.8K 0.01% 842
2020
Q2 		$2.27M Sell
38,434
-1,546
-4% -$86K 0.01% 721
2020
Q1 		$1.89M Sell
39,980
-3,194
-7% -$178K 0.02% 714
2019
Q4 		$2.61M Sell
43,174
-1,595
-4% -$95K 0.02% 686
2019
Q3 		$2.68M Sell
44,769
-79,737
-64% -$5.2M 0.02% 644
2019
Q2 		$8M Buy
124,506
+4,159
+3% +$294K 0.06% 316
2019
Q1 		$9.77M Buy
120,347
+68,651
+133% +$4.43M 0.08% 271
2018
Q4 		$2.79M Buy
51,696
+554
+1% +$28.3K 0.03% 524
2018
Q3 		$2.64M Sell
51,142
-566
-1% -$26.6K 0.02% 610
2018
Q2 		$2.15M Buy
51,708
+2,461
+5% +$109K 0.02% 654
2018
Q1 		$2.17M Buy
49,247
+375
+0.8% +$19.1K 0.02% 624
2017
Q4 		$2.46M Buy
48,872
+5,818
+14% +$319K 0.03% 579
2017
Q3 		$2.18M Sell
43,054
-9,209
-18% -$482K 0.02% 572
2017
Q2 		$2.66M Buy
52,263
+2,573
+5% +$120K 0.03% 472
2017
Q1 		$2M Buy
49,690
+5,314
+12% +$239K 0.03% 559
2016
Q4 		$2.12M Buy
44,376
+12,738
+40% +$504K 0.03% 478
2016
Q3 		$1.16M Sell
31,638
-21,514
-40% -$673K 0.02% 600
2016
Q2 		$1.24M Buy
53,152
+28,171
+113% +$909K 0.03% 369
2016
Q1 		$1.01M Buy
24,981
+21,661
+652% +$880K 0.03% 518
2015
Q4 		$206K Buy
+3,320
New +$179K 0.01% 1222

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janney Montgomery Scott's IONS Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 4,177 shares — an estimated $330K sold.

Janney Montgomery Scott first reported a position in IONS in Q4 2015 and held it in 38 quarters. The position peaked at $9.77M in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Janney Montgomery Scott reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,177 Ionis Pharmaceuticals shares in Q1 2026, an estimated $330K.
  • Janney Montgomery Scott first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 38 quarters.
  • Janney Montgomery Scott's Ionis Pharmaceuticals position peaked at $9.77M in Q1 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.